company background image
GDS

Ramsay Générale de Santé ENXTPA:GDS Stock Report

Last Price

€23.80

Market Cap

€2.6b

7D

-0.4%

1Y

22.4%

Updated

28 May, 2022

Data

Company Financials
GDS fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health2/6
Dividends0/6

GDS Stock Overview

Ramsay Générale de Santé SA operates hospitals in France.

Ramsay Générale de Santé Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Ramsay Générale de Santé
Historical stock prices
Current Share Price€23.80
52 Week High€24.80
52 Week Low€18.15
Beta-0.14
1 Month Change-0.42%
3 Month Change13.33%
1 Year Change22.37%
3 Year Change40.83%
5 Year Change58.35%
Change since IPO13,500.00%

Recent News & Updates

Mar 29
Return Trends At Ramsay Générale de Santé (EPA:GDS) Aren't Appealing

Return Trends At Ramsay Générale de Santé (EPA:GDS) Aren't Appealing

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Feb 01
If You Like EPS Growth Then Check Out Ramsay Générale de Santé (EPA:GDS) Before It's Too Late

If You Like EPS Growth Then Check Out Ramsay Générale de Santé (EPA:GDS) Before It's Too Late

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...

Dec 05
Slowing Rates Of Return At Ramsay Générale de Santé (EPA:GDS) Leave Little Room For Excitement

Slowing Rates Of Return At Ramsay Générale de Santé (EPA:GDS) Leave Little Room For Excitement

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...

Oct 30
Here's Why We Think Ramsay Générale de Santé (EPA:GDS) Is Well Worth Watching

Here's Why We Think Ramsay Générale de Santé (EPA:GDS) Is Well Worth Watching

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...

Shareholder Returns

GDSFR HealthcareFR Market
7D-0.4%3.0%3.7%
1Y22.4%-44.5%-3.7%

Return vs Industry: GDS exceeded the French Healthcare industry which returned -44.5% over the past year.

Return vs Market: GDS exceeded the French Market which returned -3.7% over the past year.

Price Volatility

Is GDS's price volatile compared to industry and market?
GDS volatility
GDS Average Weekly Movement2.6%
Healthcare Industry Average Movement5.2%
Market Average Movement5.9%
10% most volatile stocks in FR Market10.0%
10% least volatile stocks in FR Market3.4%

Stable Share Price: GDS is less volatile than 75% of French stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: GDS's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198732,623Pascal Rochehttps://www.ramsaygds.fr

Ramsay Générale de Santé SA operates hospitals in France. Its hospitals offer a range of services in the areas of anesthesia, oncology, cardiology, dermatology, gastroenterology, gynecology, maternity, nephrology, neurosurgery, obesity, ophthalmology, orthopedics, stomatology, pneumonology, psychiatry, radiology, and urology, as well as thoracic, vascular, and endovascular surgeries. The company was formerly known as Générale de Santé SA and changed its name to Ramsay Générale de Santé SA in December 2015.

Ramsay Générale de Santé Fundamentals Summary

How do Ramsay Générale de Santé's earnings and revenue compare to its market cap?
GDS fundamental statistics
Market Cap€2.63b
Earnings (TTM)€77.30m
Revenue (TTM)€4.15b

34.0x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
GDS income statement (TTM)
Revenue€4.15b
Cost of Revenue€3.02b
Gross Profit€1.13b
Other Expenses€1.05b
Earnings€77.30m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.70
Gross Margin27.25%
Net Profit Margin1.86%
Debt/Equity Ratio159.1%

How did GDS perform over the long term?

See historical performance and comparison

Valuation

Is Ramsay Générale de Santé undervalued compared to its fair value and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


33.98x

Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate GDS's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate GDS's fair value for valuation analysis.


Price To Earnings Ratio

PE vs Industry: GDS is poor value based on its Price-To-Earnings Ratio (34x) compared to the French Healthcare industry average (19.5x).

PE vs Market: GDS is poor value based on its Price-To-Earnings Ratio (34x) compared to the French market (16.2x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate GDS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: GDS is overvalued based on its Price-To-Book Ratio (2.3x) compared to the FR Healthcare industry average (1.9x).


Future Growth

How is Ramsay Générale de Santé forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


13.9%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ramsay Générale de Santé has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Ramsay Générale de Santé performed over the past 5 years?

Past Performance Score

3/6

Past Performance Score 3/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


17.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: GDS has a large one-off loss of €163.3M impacting its December 31 2021 financial results.

Growing Profit Margin: GDS's current net profit margins (1.9%) are higher than last year (1.6%).


Past Earnings Growth Analysis

Earnings Trend: GDS's earnings have grown by 17.6% per year over the past 5 years.

Accelerating Growth: GDS's earnings growth over the past year (27.3%) exceeds its 5-year average (17.6% per year).

Earnings vs Industry: GDS earnings growth over the past year (27.3%) underperformed the Healthcare industry 27.3%.


Return on Equity

High ROE: GDS's Return on Equity (7.4%) is considered low.


Financial Health

How is Ramsay Générale de Santé's financial position?

Financial Health Score

2/6

Financial Health Score 2/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: GDS's short term assets (€1.3B) do not cover its short term liabilities (€1.3B).

Long Term Liabilities: GDS's short term assets (€1.3B) do not cover its long term liabilities (€4.1B).


Debt to Equity History and Analysis

Debt Level: GDS's net debt to equity ratio (123.9%) is considered high.

Reducing Debt: GDS's debt to equity ratio has reduced from 220.5% to 159.1% over the past 5 years.

Debt Coverage: GDS's debt is not well covered by operating cash flow (7.2%).

Interest Coverage: GDS's interest payments on its debt are well covered by EBIT (3.4x coverage).


Balance Sheet


Dividend

What is Ramsay Générale de Santé current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate GDS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate GDS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if GDS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if GDS's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: GDS is not paying a notable dividend for the French market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as GDS has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

3.3yrs

Average management tenure


CEO

Pascal Roche (59 yo)

10.92yrs

Tenure

€1,282,920

Compensation

Mr. Pascal Roche has been the Chairman of the Board and Chief Executive Officer of Capio AB (publ) since December 4, 2018. Mr. Roche has been the Chief Executive Officer at Ramsay Générale de Santé SA sinc...


CEO Compensation Analysis

Compensation vs Market: Pascal's total compensation ($USD1.37M) is about average for companies of similar size in the French market ($USD1.67M).

Compensation vs Earnings: Pascal's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: GDS's management team is considered experienced (3.3 years average tenure).


Board Members

Experienced Board: GDS's board of directors are considered experienced (4.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Ramsay Générale de Santé SA's employee growth, exchange listings and data sources


Key Information

  • Name: Ramsay Générale de Santé SA
  • Ticker: GDS
  • Exchange: ENXTPA
  • Founded: 1987
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Implied Market Cap: €2.627b
  • Shares outstanding: 110.36m
  • Website: https://www.ramsaygds.fr

Number of Employees


Location

  • Ramsay Générale de Santé SA
  • 39 rue Mstislav Rostropovitch
  • Paris
  • Ile-de-France
  • 75017
  • France

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/28 00:00
End of Day Share Price2022/05/27 00:00
Earnings2021/12/31
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.